BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20131239)

  • 21. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
    Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC
    Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replication of the association between the C8orf13-BLK region and systemic lupus erythematosus in a Japanese population.
    Ito I; Kawasaki A; Ito S; Hayashi T; Goto D; Matsumoto I; Tsutsumi A; Hom G; Graham RR; Takasaki Y; Hashimoto H; Ohashi J; Behrens TW; Sumida T; Tsuchiya N
    Arthritis Rheum; 2009 Feb; 60(2):553-8. PubMed ID: 19180478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis.
    Kawasaki A; Tsuchiya N; Fukazawa T; Hashimoto H; Tokunaga K
    Genes Immun; 2002 Nov; 3(7):424-9. PubMed ID: 12424625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus.
    Velázquez-Cruz R; Orozco L; Espinosa-Rosales F; Carreño-Manjarrez R; Solís-Vallejo E; López-Lara ND; Ruiz-López IK; Rodríguez-Lozano AL; Estrada-Gil JK; Jiménez-Sánchez G; Baca V
    Eur J Hum Genet; 2007 Mar; 15(3):336-41. PubMed ID: 17228327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis.
    Carulli MT; Spagnolo P; Fonseca C; Welsh KI; duBois RM; Black CM; Denton CP
    J Rheumatol; 2008 May; 35(5):839-44. PubMed ID: 18381789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus.
    Sung YK; Park BL; Shin HD; Kim LH; Kim SY; Bae SC
    Rheumatology (Oxford); 2006 Apr; 45(4):400-4. PubMed ID: 16287924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysis.
    Coustet B; Dieudé P; Guedj M; Bouaziz M; Avouac J; Ruiz B; Hachulla E; Diot E; Cracowski JL; Tiev K; Sibilia J; Mouthon L; Frances C; Amoura Z; Carpentier P; Cosnes A; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2011 Jul; 63(7):2091-6. PubMed ID: 21480188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence.
    Zhou X; Tan FK; Wang N; Xiong M; Maghidman S; Reveille JD; Milewicz DM; Chakraborty R; Arnett FC
    Arthritis Rheum; 2003 Sep; 48(9):2585-92. PubMed ID: 13130478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease.
    Fatini C; Mannini L; Sticchi E; Rogai V; Guiducci S; Conforti ML; Cinelli M; Pignone AM; Bolli P; Abbate R; Cerinic MM
    Arthritis Rheum; 2006 Jul; 54(7):2263-70. PubMed ID: 16802365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.
    Tang L; Chen B; Ma B; Nie S
    Genet Mol Res; 2014 Jun; 13(2):4473-85. PubMed ID: 25036352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population.
    Baca V; Velázquez-Cruz R; Salas-Martínez G; Espinosa-Rosales F; Saldaña-Alvarez Y; Orozco L
    Genes Immun; 2006 Dec; 7(8):693-5. PubMed ID: 17066073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population.
    Järvinen TM; Hellquist A; Zucchelli M; Koskenmies S; Panelius J; Hasan T; Julkunen H; D'Amato M; Kere J
    Rheumatology (Oxford); 2012 Jan; 51(1):87-92. PubMed ID: 22039224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variants of chemokine receptor CCR7 in patients with systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis.
    Kahlmann D; Davalos-Misslitz AC; Ohl L; Stanke F; Witte T; Förster R
    BMC Genet; 2007 Jun; 8():33. PubMed ID: 17587445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.
    Kyogoku C; Dijstelbloem HM; Tsuchiya N; Hatta Y; Kato H; Yamaguchi A; Fukazawa T; Jansen MD; Hashimoto H; van de Winkel JG; Kallenberg CG; Tokunaga K
    Arthritis Rheum; 2002 May; 46(5):1242-54. PubMed ID: 12115230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of DNase IV polymorphisms with autoantibodies in patients with systemic lupus erythematosus.
    Kim I; Hur NW; Shin HD; Park BL; Cheong HS; Bae SC
    Rheumatology (Oxford); 2008 Jul; 47(7):996-9. PubMed ID: 18417526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome.
    Nordmark G; Kristjansdottir G; Theander E; Appel S; Eriksson P; Vasaitis L; Kvarnström M; Delaleu N; Lundmark P; Lundmark A; Sjöwall C; Brun JG; Jonsson MV; Harboe E; Gøransson LG; Johnsen SJ; Söderkvist P; Eloranta ML; Alm G; Baecklund E; Wahren-Herlenius M; Omdal R; Rönnblom L; Jonsson R; Syvänen AC
    Genes Immun; 2011 Mar; 12(2):100-9. PubMed ID: 20861858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in STAT4 is associated with systemic lupus erythematosus in a Finnish family cohort.
    Hellquist A; Sandling JK; Zucchelli M; Koskenmies S; Julkunen H; D'Amato M; Garnier S; Syvänen AC; Kere J
    Ann Rheum Dis; 2010 May; 69(5):883-6. PubMed ID: 19717398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association.
    Zhou X; Tan FK; Stivers DN; Arnett FC
    Arthritis Rheum; 2000 May; 43(5):1068-73. PubMed ID: 10817561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics research in systemic lupus erythematosus for clinicians: methodology, progress, and controversies.
    Kaiser R; Criswell LA
    Curr Opin Rheumatol; 2010 Mar; 22(2):119-25. PubMed ID: 20035223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.